Tag: Health care industry
-
Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production
Eli Lilly is trying to catch up in the GLP-1 pill market to Novo, which got a head start in the space.
-
Beauty, health and wellness are converging into one retail category
As consumers prioritize holistic retail purchases, beauty, health and wellness are increasingly converging into one category and one consumer budget.
-
Athletes with autism take center court at the US Open
Young athletes with autism were on the US Open courts with Love Serving Autism, using racquet sports to build confidence, connection and life skills.
-
Novo Nordisk rebrands to ‘Novo,’ unveils corporate changes as it fights for obesity market share
The Danish drugmaker called the changes the beginning of a new chapter for the company, which faces stiff competition from Eli Lilly.
-
Record U.S. cyclosporiasis outbreak is over, CDC says
The largest outbreak, linked to shredded iceberg lettuce from Taylor Farms, sickened more than 12,000 people.
-
A rare disease is taking his vision. A gene therapy could help — if he can get it
A well-connected family’s fight to access a potential treatment for their son highlights the barriers most rare disease patients struggle to overcome.
-
‘Patients pay the tariff’: Swiss pharma CEO warns of Trump’s generic drug tariff threat
Sandoz CEO Richard Saynor warns steep U.S. tariffs on imported generic drugs could force manufacturers to raise prices or cut supply.
-
AstraZeneca’s COPD drug scores two late-stage trial wins as full data boosts blockbuster hopes
The full data reinforces hopes that the drug could be a breakthrough COPD treatment and reach AstraZeneca’s peak annual sales forecast of more than $5 billion.
-
Pharma major Novartis falls nearly 10%, heading for worst day on record after three drug trial setbacks
Shares of Novartis tanked on Tuesday after results from its del-desiran drug trial disappointed investors.
-
Cholesterol drug setback casts doubt over multibillion-dollar race
Novartis’ failure raises the stakes for Amgen and Eli Lilly in the race to turn lower Lp(a) levels into fewer heart attacks and strokes.
Latest News
Stay Connected
Categories
BBC News CNA CNBC CNN International Deutsche Welle (DW) Euronews France 24 General Global & European Specialized & Regional
Tags
amp Artificial intelligence Asia Breaking News: Business Breaking News: Markets Breaking News: Politics Breaking News: Technology Business business news cent china cup Donald J. Trump Donald Trump economy European Union fast football France germany india Investment strategy iran Iran war markets People per politics return russia S&P 500 Index said Singapore spain Sport Stock markets technology trump ukraine United States US-Israel attack on Iran 2026 video War in Ukraine World World Cup 2026
About the Author
AF themes
Easy WordPress Websites Builder: Versatile Demos for Blogs, News, eCommerce and More – One-Click Import, No Coding! 1000+ Ready-made Templates for Stunning Newspaper, Magazine, Blog, and Publishing Websites.
Search the Archives
Access over the years of investigative journalism and breaking reports
You May Have Missed
